BIOREGENX, INC. (BRGX) Financial Statements (2026 and earlier)

Company Profile

Business Address 7407 ZIEGLER ROAD
CHATTANOOGA, TN 37421
State of Incorp. NV
Fiscal Year End December 31
Industry (SIC) 737 - Computer Programming, Data Processing, And Other Computer Related Services (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2025
Q3
6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments4684587057114
Cash and cash equivalent4684587057114
Receivables2111151911103
Inventory, net of allowances, customer advances and progress billings134140111159144409
Inventory134140111159144409
Prepaid expense55555 
Other current assets435411873109173
Other undisclosed current assets    44 129
Total current assets:250294308371326928
Noncurrent Assets
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization176188201213225581
Long-term investments and receivables      718
Long-term investments      263
Accounts and financing receivable, after allowance for credit loss      455
Intangible asset, including goodwill, after accumulated amortization725  16,77717,33917,062
Goodwill    7,1067,106 
Intangible asset, excluding goodwill, after accumulated amortization725  9,67210,23417,062
Other noncurrent assets      0
Other undisclosed noncurrent assets      1,227
Total noncurrent assets:90118820116,99017,56519,588
TOTAL ASSETS:1,15148350917,36117,89120,516
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities9741,0058809198301,179
Accounts payable569491427493432613
Accrued liabilities405515453427398566
Deferred revenue125189197166196333
Debt9708818838758511,842
Other undisclosed current liabilities1,8561,7091,6721,5581,543 
Total current liabilities:3,9263,7843,6333,5183,4203,355
Noncurrent Liabilities
Long-term debt and lease obligation359257255282250150
Long-term debt, excluding current maturities359257255282250150
Other undisclosed noncurrent liabilities520     
Total noncurrent liabilities:880257255282250150
Total liabilities:4,8054,0423,8883,8013,6703,505
Equity
Equity, attributable to parent, including:(3,655)(3,559)(3,379)13,56114,22117,011
Common stock961960957957957957
Additional paid in capital31,40931,32030,96529,77830,04125,941
Accumulated other comprehensive income (loss) (7)(0)2(2)10
Accumulated deficit(36,017)(35,839)(35,572)(17,171)(16,777)(10,167)
Other undisclosed equity, attributable to parent0026900281
Total equity:(3,655)(3,559)(3,379)13,56114,22117,011
TOTAL LIABILITIES AND EQUITY:1,15148350917,36117,89120,516

Income Statement (P&L) ($ in thousands)

9/30/2025
Q3
6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
Revenues446515460596734618
Cost of revenue(94)(109)(138)(114)(264)(159)
Financing interest expense  (74)(84)(68)(66)(69)
Gross profit:352406323482470459
Operating expenses(460)(599)(18,640)(809)(1,510)(1,096)
Operating loss:(107)(193)(18,317)(327)(1,040)(637)
Nonoperating expense    (68)(66)(68)
Interest and debt expense (10)(4)   
Other undisclosed income from continuing operations before equity method investments, income taxes   207   
Net loss:(107)(202)(18,114)(395)(1,106)(705)
Other undisclosed net loss attributable to parent (71)(64)(287)   
Net loss available to common stockholders, diluted:(178)(267)(18,401)(395)(1,106)(705)

Comprehensive Income ($ in thousands)

9/30/2025
Q3
6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
Net loss:(107)(202)(18,114)(395)(1,106)(705)
Comprehensive loss:(107)(202)(18,114)(395)(1,106)(705)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(78)(67)(283)(3)11
Comprehensive loss, net of tax, attributable to parent:(186)(269)(18,397)(397)(1,106)(704)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: